Timing of blood purification therapy in acute pancreatitis with systemic inflammatory response syndrome
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 7
Abstract
"<b>Objective</b> To explore the timing of blood purification (BP) therapy in patients with acute pancreatitis (AP) who develop systemic inflammatory response syndrome (SIRS). <b>Methods</b> A retrospective collection was made of 254 AP patients with SIRS who underwent BP treatment at the Affiliated Baiyun Hospital of Guizhou Medical University from May 2015 to May 2023, and at the Affiliated Hospital of Guizhou Medical University from September 2021 to April 2023. Patients were divided into Group A (＜6 h,n=62), Group B (6-12 h,n=52), Group C (＜12-24 h,n=52), and Group D (＞24 h,n=88) based on the time from SIRS onset to BP treatment. Mortality rate, rate of patient's request for discharge, local complications, systemic complications, ICU transfer, mechanical ventilation, hospital stay, and treatment costs were used as prognostic indicators to study the impact of different BP treatment times on these indicators. <b>Results</b> The incidences of acute peripancreatic fluid collection and renal failure in Groups C and D were significantly higher than those in Group A (P＜0.05); the incidences of circulatory failure and mechanical ventilation in Group D were significantly higher than those in Group A (P＜0.05); the incidence of coagulation dysfunction in Groups C and D was significantly higher than that in Groups A and B (P＜0.05); the incidence of patients transferred to ICU in Groups B, C, and D was higher than that in Group A (P＜0.05); the hospital stay and treatment costs for patients in Group D were significantly higher than those in Groups A, B, and C (P＜0.05). <b>Conclusion</b> BP treatment within 6 hours of diagnosing SIRS can reduce the incidence of patient transfer to ICU; BP treatment within 12 hours can reduce the incidence of pancreatic exudate, renal failure, and coagulation dysfunction; BP treatment within 24 hours can reduce the incidence of circulatory failure and mechanical ventilation, as well as decrease hospital stay and treatment costs."
Authors and Affiliations
GUO Shasha*, LEI Jingjing, WANG Yujie, GE Jingfan
Keywords
Related Articles
- EP ID EP740734
- DOI 10.13429/j.cnki.cjcr.2024.07.021
- Views 30
- Downloads 1
Effects of remimazolam combined with mivacurium on recovery quality of patients after vocal cord polypectomy
"<b>Objective</b> To evaluate the effects of remimazolam versus propofol on the quality of postoperative recovery in patients undergoing vocal cord polypectomy with supportive laryngoscopy by the 15-item quality of reco...
Endoscopic vein harvesting in coronary artery bypass grafting
<b>Objective</b> To evaluate the early clinical effect of the application of endoscopy in coronary artery bypass grafting to obtain the great saphenous vein.<b>Methods</b> A total of 262 patients with great saphenous v...
Diagnostic value of AFP, CEA and HSP90a in primary liver cancer based on the prediction model
Objective To construct a predictive model to analyze the diagnostic value of serum alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), heat shock protein 90a (Hsp90a) for primary liver cancer (PHC). Methods A retr...
Research progress in sensitivity to inhalation anesthetics
Inhalation anesthetics have both sedative, analgesic and muscle relaxing effects,and are widely used in clinical practice. Hypersensitivity to inhalation anesthetics predicts poor postoperative outcomes. Current studies...
Efficacy and immunomodulatory effect of anlotinib combined with GP regimen in the treatment of advanced non-small cell lung cancer
<b>Objective</b> To explore the clinical efficacy and immunomodulatory effects of anlotinib capsule combined with GP regimen in the treatment of advanced non-small cell lung cancer(NSCLC). <b>Methods</b> Forty patients w...